Rating History for Monopar Therapeutics (MNPR) by Cantor Fitzgerald
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/13/2026 | Kirsten Kluska | Downgrade | Neutral (Overweight) |
119.00 (109.00) |
114.46 (118.52) |
3.55% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
